BeyondSpring Inc. logo

BeyondSpring Inc.

NASDAQ:BYSI

Overview | Financials
Company Name BeyondSpring Inc.
Symbol BYSI
Currency USD
Price 2.39
Market Cap 96,317,956
Dividend Yield 0%
52-week-range 0.778 - 4
Industry Biotechnology
Sector Healthcare
CEO Dr. Lan Huang Ph.D.
Website https://www.beyondspringpharma.com

An error occurred while fetching data.

About BeyondSpring Inc.

BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and for treatment of later-stage non-small cell

Related Stocks

Sera Prognostics, Inc. logo

Sera Prognostics, Inc.

SERA

7.71 USD

ProQR Therapeutics N.V. logo

ProQR Therapeutics N.V.

PRQR

4.49 USD

MiNK Therapeutics, Inc. logo

MiNK Therapeutics, Inc.

INKT

0.67 USD

Freeline Therapeutics Holdings plc logo

Freeline Therapeutics Holdings plc

FRLN

6.49 USD

BioSig Technologies, Inc. logo

BioSig Technologies, Inc.

BSGM

0.31 USD

Corvus Pharmaceuticals, Inc. logo

Corvus Pharmaceuticals, Inc.

CRVS

7.21 USD

Syros Pharmaceuticals, Inc. logo

Syros Pharmaceuticals, Inc.

SYRS

1.95 USD

Financials

Numbers are in millions USD

Numbers are in millions USD